Baseline Clinical Characteristics of Ambulatory Monitoring Patients According to Treatment Strategy, and Compared to Remaining, Non-Ambulatory Monitoring INVEST Patients.

Data are presented as mean (SD) or number (percent).BMI, body mass index; CABG, coronary artery bypass graft; INVEST, INternational VErapamil SR-Trandolapril STudy; LVH, left ventricular hypertrophy; PCI, percutaneous coronary intervention; SD, standard deviation; TIA, transient ischemic attack.aComparing ambulatory monitoring study patients randomized to verapamil SR- vs. atenolol-based treatment strategies, P value uniformly nonsignificant.bComparing all ambulatory monitoring INVEST study patients with remaining, non-ambulatory monitoring patients.cPatients taking beta-blockers within 2 weeks of randomization or taking beta-blockers for an MI that occurred in the previous 12 months were excluded from INVEST to avoid withdrawal phenomena in patients randomized to the verapamil-based treatment strategy [31].Baseline Clinical Characteristics of Ambulatory Monitoring Patients According to Treatment Strategy, and Compared to Remaining, Non-Ambulatory Monitoring INVEST Patients.